Healthcare provider profile · identity verified

Ryan Andrew Flannery, M.D.

Family Practice · WASHINGTON, IA · NPI 1114981396

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	316	68
Atorvastatin Calcium	Atorvastatin Calcium	301	76
Pantoprazole Sodium	Pantoprazole Sodium	202	47
Celecoxib	Celecoxib	200	49
Losartan Potassium	Losartan Potassium	174	37
Lisinopril	Lisinopril	164	38
Meloxicam	Meloxicam	149	35
Furosemide	Furosemide	136	27
Gabapentin	Gabapentin	127	26
Metoprolol Succinate	Metoprolol Succinate	125	35
Tamsulosin Hcl	Tamsulosin Hcl	125	32
Potassium Chloride	Potassium Chloride	119	21
Omeprazole	Omeprazole	117	29
Simvastatin	Simvastatin	116	31
Amlodipine Besylate	Amlodipine Besylate	98	31
Rosuvastatin Calcium	Rosuvastatin Calcium	86	22
Duloxetine Hcl	Duloxetine Hcl	76	12
Metformin Hcl Er	Metformin Hcl	73	23
Escitalopram Oxalate	Escitalopram Oxalate	72	19
Eliquis	Apixaban	71	11
Finasteride	Finasteride	71	18
Hydrochlorothiazide	Hydrochlorothiazide	68	22
Prednisone	Prednisone	64	42
Bupropion Xl	Bupropion Hcl	63	11
Nabumetone	Nabumetone	60	13
Jardiance	Empagliflozin	59	11
Alprazolam	Alprazolam	58	12
Trazodone Hcl	Trazodone Hcl	57	12
Warfarin Sodium	Warfarin Sodium	56	suppressed
Montelukast Sodium	Montelukast Sodium	55	14
Allopurinol	Allopurinol	53	12
Sertraline Hcl	Sertraline Hcl	50	14
Tramadol Hcl	Tramadol Hcl	50	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	12
Albuterol Sulfate Hfa	Albuterol Sulfate	48	18
Esomeprazole Magnesium	Esomeprazole Magnesium	47	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Pregabalin	Pregabalin	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	11
Ozempic	Semaglutide	44	suppressed
Lorazepam	Lorazepam	41	11
Metformin Hcl	Metformin Hcl	41	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	24
Clonazepam	Clonazepam	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Atenolol	Atenolol	31	suppressed
Dutasteride	Dutasteride	31	suppressed
Famotidine	Famotidine	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Cefdinir	Cefdinir	28	26
Irbesartan	Irbesartan	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	17
Enalapril Maleate	Enalapril Maleate	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Cephalexin	Cephalexin	23	19
Doxycycline Hyclate	Doxycycline Hyclate	23	14
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Fluconazole	Fluconazole	21	16
Levemir Flexpen	Insulin Detemir	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Azithromycin	Azithromycin	20	18
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Myrbetriq	Mirabegron	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Budesonide Dr	Budesonide	17	suppressed
Febuxostat	Febuxostat	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Intrarosa	Prasterone (Dhea)	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error